Official announcements
Searched for "covid".
messages in brief
|
18/12/2020
In Austria, adverse reactions can be voluntarily reported directly to the Federal Office for Safety in Health Care (BASG) by patients as well as their relatives.
Safety warnings
|
Blood & Tissue
|
03/12/2020
An update on CCP (COVID-19 Convalescent Plasma) has been forwarded by the European Commission to the Federal Office for Safety in Health Care.
Enforcement
|
11/11/2020
MMS (Miracle Mineral Solution or Master Mineral Solution) and CDs (Chloride dioxide solution or German: Chlordioxidlösung - CDL) are two different starting products for the generation of gaseous chlorine dioxide, which is offered in alternative medical circles as a "cure" for various diseases, including COVID-19. However, there is no scientific evidence of the claimed beneficial effects of chlorine dioxide, which is a gas that can cause burns and symptoms of poisoning.
messages in brief
|
10/11/2020
Keine Wirkung gegen COVID-19 und begründeter Verdacht auf schädliche Wirkungen.
messages in brief
|
24/09/2020
Three different test methods for the detection of COVID-19 are currently in use in Austria: PCR (polymerase chain reaction) tests, antibody tests and antigen tests.
messages in brief
|
30/06/2020
Also in the future, we want to continue to inform our applicants of marketing authorisation procedures with Austria as RMS with relevant news from the committees or exciting innovations such as the slot application via our eServices!
messages in brief
|
25/06/2020
Bedingte Zulassung für Wirkstoff Remdesivir, für Erwachsene und Jugendliche ab 12 Jahren mit COVID-19 Lungenentzündung die Sauerstoff benötigen, empfohlen
messages in brief
|
24/06/2020
Die Warnung umfasst Produkte die außerhalb von legalen Apotheken angeboten werden
messages in brief
|
29/05/2020
Vorteilhafte Wirkung nicht belegt, aber Hinweise auf gravierende Nebenwirkungen
Blood & Tissue
|
14/05/2020
The Federal Office for Safety in Health Care received a document and various links by the Dutch authority regarding adverse events and reactions related to cryopreservation of stem cell products during the COVID-19 pandemic.